πŸ‡ΊπŸ‡Έ FDA
Patent

US 8163935

Fused heterocyclic compounds

granted A61PA61P25/00A61P25/22

Quick answer

US patent 8163935 (Fused heterocyclic compounds) held by Takeda Pharmaceutical Company Limited expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P25/00, A61P25/22, A61P25/24, A61P3/10